Parkinson's disease is a recognisable clinical syndrome with a range of causes and clinical
presentations. Parkinson's disease represents a fast-growing neurodegenerative condition; …

Given the high prevalence of individuals diagnosed with substance use disorder, along with
the elevated rate of relapse following treatment initiation, investigating novel approaches …

Background Magnetic resonance guided focused ultrasound (MRgFUS) is United States
Food and Drug Administration approved for the treatment of tremor‐dominant Parkinson's …

MR‐guided focused ultrasound is a novel, minimally invasive surgical procedure for
symptomatic treatment of PD. With this technology, the ventral intermediate nucleus, STN …

Background: MRI-guided focused ultrasound (FUS) has established short-term efficacy in
tremor relief. Objective: We report our long-term experience of treating tremor with unilateral …

Parkinson's disease (PD) is the second more common neurodegenerative disease with
increasing incidence worldwide associated to the population ageing. Despite increasing …

Transcranial magnetic resonance (MR)-guided focused ultrasound (FUS) therapy is an
emerging and minimally invasive treatment for movement disorders. There are limited …

Tremor is a debilitating symptom that can lead to functional impairment. Pharmacotherapy is
often successful, but up to 50% of patients are resistant to medications or cannot tolerate …

There has been a long history of lesioning procedures to treat tremor associated with both
essential tremor (ET) and Parkinson's disease (PD). These include radiofrequency (RF) …

Subthalamotomy using transcranial magnetic resonance-guided focused ultrasound
(tcMRgFUS) is a novel and promising treatment for Parkinson's Disease (PD). In this study …